Inhibition of DNA synthesis and cancer therapies

Fuyuhiko Tamanoi1, Kenichi Yoshikawa2

  • 1Institute for Integrated Cell-Material Sciences, Institute for Advanced Study, Kyoto University, Kyoto, Japan.

The Enzymes
|November 24, 2022
PubMed

Insights

Novel Auger therapy uses high Z nanoparticles to deliver targeted DNA damage for cancer treatment. This approach localizes radiation near DNA, enhancing tumor destruction compared to conventional X-ray therapy.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Nanomedicine

Background:

  • Cancer remains a significant global health challenge, necessitating advanced therapeutic strategies.
  • Current cancer treatments, including chemotherapy and conventional radiation, target DNA synthesis or integrity.
  • Limitations exist in conventional therapies, driving research into more targeted approaches.

Purpose of the Study:

  • To introduce and evaluate Auger therapy as a novel radiation modality for cancer treatment.
  • To investigate the efficacy of high Z element-loaded nanoparticles in localizing DNA-damaging radiation.
  • To compare the DNA-damaging potential of Auger therapy with conventional X-ray therapy.

Main Methods:

  • Development of nanoparticles loaded with high Z elements (gadolinium or iodine).
  • Localization of nanoparticles to the nuclear periphery for proximity to DNA.
  • Irradiation using monochromatic X-rays to induce Auger electron emission.
  • Assessment of DNA double-strand breaks and tumor destruction.

Main Results:

  • Nanoparticles successfully localized high Z elements near the cell nucleus.
  • Irradiation induced Auger electron release, causing significant DNA double-strand breaks.
  • Tumor mass destruction was observed, indicating therapeutic potential.
  • Auger therapy demonstrated a distinct mechanism of DNA damage compared to conventional X-rays.

Conclusions:

  • Auger therapy offers a targeted approach to cancer treatment by exploiting Auger electron emission from high Z elements.
  • Nanoparticle delivery enhances the localization of radiation dose to the DNA, potentially increasing efficacy and reducing side effects.
  • This novel radiation strategy shows promise for improving tumor destruction in cancer therapy.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K